telisotuzumab vedotin teliso v

Keyword Analysis

Keyword	CPC	PCC	Volume	Score	Length of keyword
telisotuzumab vedotin teliso v	1.39	0.4	7492	86	30
telisotuzumab	0.37	0.2	1672	3	13
vedotin	0.8	1	55	10	7
teliso	0.74	0.5	5725	1	6
v	1.06	0.4	9893	73	1

Keyword	CPC	PCC	Volume	Score
telisotuzumab vedotin teliso-v	1.66	0.1	9717	59
telisotuzumab vedotin mechanism of action	1.13	0.6	468	8
telisotuzumab vedotin fda approval	1.69	0.1	2769	8
telisotuzumab vedotin phase 3	0.07	0.3	4262	13
telisotuzumab vedotin lung cancer	0.3	1	8382	49
telisotuzumab vedotin abbv-399	1.17	1	6811	99
polatuzumab vedotin patient information	1.48	0.3	4083	62
polatuzumab vedotin j code	1.9	0.1	4004	52
polatuzumab vedotin scheda tecnica	0.57	0.3	7295	21
polatuzumab vedotin mechanism of action	1.4	0.7	4082	11
polatuzumab vedotin prescribing information	0.73	0.7	167	53
polatuzumab vedotin fda label	1.46	0.6	2562	10
polatuzumab vedotin fda approval	1.07	0.4	7673	48
polatuzumab vedotin fda approval history	1.32	0.5	7646	9
polatuzumab vedotin-piiq	1.6	0.1	9999	53
telisotuzumab-vedotin	1.24	0.9	1929	85
mechanism of action of vedolizumab	1.15	0.4	7880	50
tisotumab vedotin mechanism of action	1.37	0.2	3481	76
vedolizumab mode of action	0.58	0.1	4694	15